Results 161 to 170 of about 25,729 (211)

Human body temperature cues widespread changes in virulence gene expression in uropathogenic <i>Escherichia coli</i>. [PDF]

Infect Immun
Dehner CA, Stankovic IN, Sutherland M, Bierwert LA, Dimova KP, Scordilis SP, Stoebel DM, White-Ziegler CA.   +7 more
europepmc   +1 more source

NeuO-mediated O-acetylation of uropathogenic <i>Escherichia coli</i> K1 capsule enhances resistance to phage and neutrophil killing. [PDF]

J Bacteriol
Walker LL, Nhu NTK, Lian ZJ, Peters KM, Monteleone M, Connolly JPR, Walker MJ, Forde BM, Schroder K, Sweet MJ, Phan M-D, Schembri MA.   +11 more
europepmc   +1 more source

Canine urothelial cell model to study intracellular bacterial community development by uropathogenic Escherichia coli. [PDF]

PLoS One
Gilbertie JM, Sheahan BJ, Vaden SL, Jacob ME.   +3 more
europepmc   +1 more source

Determination of Effective Prophylactic Responses of Truncated Flagellin Protein as a Vaccine Candidate Against Uropathogenic <i>Escherichia coli</i>. [PDF]

Int J Microbiol
Dehvari A, Bameri Z, Asadi Karam MR, Kord E, Oloomi M, Shahraki Zahedani S, Habibi M, Hashemzahi Z.   +7 more
europepmc   +1 more source

Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel. [PDF]

BMC Microbiol
ElFeky DS, Kassem AA, Moustafa MA, Assiri H, El-Mahdy AM.   +4 more
europepmc   +1 more source

Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli. [PDF]

BMC Microbiol
Golpasand T, Keshvari M, Behzadi P.
europepmc   +1 more source

Mapping antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli across low, middle and high-income countries highlights significant differences: insights for empiric treatment. [PDF]

IJID Reg
Rizvi M, Khan M, Al-Jardani A, Al-Abri SS, Ghoshal U, Jabri ZA, Ahanjan M, Mamari AA, Shizawi NA, Sami H, Balkhair A, Shaukat A, Alkharusi ANS, Almahrouqi A, Hassan A, Kumar A, Malehi AS, Gul A, Singh A, Shidhani ASHA, Siddiqui AH, Poojary A, Rashdi AA, Langford B, Stepanskyi D, Dolatabadi A, Maani AA, Mufarji AA, AlRisi ESA, Kapoor G, Princess I, Lawati HJA, Eltahir HA, Sidairi HA, Iskandar K, Masters K, Al-Busaidi IKH, Yazidi LA, Nasrin M, Subhi MSA, Sengupta M, Khandait M, Tamtami NKA, Siyabi NKA, Kindi NA, Luthfee NM, Shreshtha N, Riyami NMAA, Busaidi NHAA, Goel N, Ishchenko O, Taher OMEA, Jena PP, Ekadashi R, Al Zadjali R, Kanungo R, Abolghasemi S, Maqbali SA, Banerjee S, Yaqoob S, Sali S, Khan SH, Malhotra S, Hughes S, Shaukat S, Atif SM, Patwardhan VV, Dougnon V, Khan W, Wali W, Muharrmi ZA, Basit Z, Choudhury J, Pravalina R, John KHS, Singh S, Singh S, Taneja N, Sardana R, Ghafur A, Kapoor P, Soman R, Abri RA.   +82 more
europepmc   +1 more source

Current Insights into Antibiotic Resistance in Uropathogenic <i>Escherichia coli</i> and Interventions Using Selected Bioactive Phytochemicals. [PDF]

Antibiotics (Basel)
Futoma-Kołoch B, Sarowska J, Abd El-Salam M, Miñana-Galbis D, Drabová B, Guz-Regner K, Wiśniewska P, Kryniewska V.   +7 more
europepmc   +1 more source

Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains. [PDF]

Arch Virol
Markusková B, Elnwrani S, Andrezál M, Sedláčková T, Szemes T, Slobodníková L, Kajsik M, Drahovská H.   +7 more
europepmc   +1 more source

Immunogenic Potential of a Multi-Peptide Vaccine Construct Against Uropathogenic Escherichia coli-Associated Urinary Tract Infection. [PDF]

Iran Biomed J
Mirsharifi S, Habibi M, Rahimi T, Foroohi F, Asadi Karam MR.   +4 more
europepmc   +1 more source